Venn Life Sciences Share Discussion Threads

[pj 1] 06/2/2017 19:22

Please totally ignore my comments ref redundancies, it was meant for the FRP thread. :-//

Apologies if any distress caused PJ

[pentangle] 01/2/2017 10:02

It is always a little worrying when there is silence, particularly with AIM companies, and like everyone else, I would be comforted to hear something. However, as has been pointed out, there is logic in waiting for the Integumen issue to be sorted.

Additionally I note that the house broker, Hybridian, raised their forecasts for 2016 and 2017 on the 8th November. At that stage there would have been high visibility on 2016 - a CRO is hardly dependent on Christmas sales and should know what the staff will be working on over the next few weeks! If the house broker does not have the inside track then I don't know who does.

[yump] 31/1/2017 08:56

On the positive side, the removal of Integumen does look like it will clarify the main business position and make it easier to see if its progressing well. Can't really argue with the logic; if it had remained, there could potentially always be an issue with figuring out if the losses were clouding the real business, or at worst were being used as an excuse. No excuses from now on. Its removal hasn't done any harm.

It may also be that if the guys in charge are more interested in money than the business, that they are actually more aligned with investors than some that are just enthusiastic about their business.

In June they said:

"Revenues for the 6 months ended 30 June 2016 will exceed EUR8.0m, a considerable increase on the comparative period last year (H1 2015: EUR4.26m). With a strong first half and good visibility on second half revenues, the Board is confident that the Company is on track to deliver full year revenues in excess of EUR16m and to record the Company's first profits at the PBT level, in-line with market expectations, as well as continue to generate free cashflows."

That was without selling Integumen. No doubt there will be exceptionals because of the sale, but the underlying figures should tell whether the idea of PBT was actually valid or not. It may be a small amount, but it should be there, given the confident AGM statement above.

[cocker] 31/1/2017 07:44

Harry Vederci, your post earlier this month on the 16th (724), at the very least deserves another read from investors.

[cocker] 26/1/2017 13:29

Totally agree with your entire post Yump. I know great gains can be had with these aim tiddler's but all to often one has to trawl through every little detail to make sure it is, what it is presented as being.

[yump] 26/1/2017 12:25

Well I think the worst case with Integumen is that having invested in it originally and loaned it £1.5mln, it ends up just being a load of shares worth very little.

ie. the £4.5mln 'sale' price isn't really a sale and the loan has disappeared into shares which will never give shareholders any value.

Given that contract was 'related party', the whole business looks a bit incestuous at the moment, especially with the involvement with Cayman Islands based hedge funds.

I don't think any pi's will ever have a clue what is going on apart from seeing results. I suppose the expectation is that all these involved parties still have stakes in driving the business to profit in order to divest.

If I'd looked into these guys properly I'd probably have only bought half the number of shares on the basis that it could give a very good return at some point, but is being run by who may be way more interested in financial dealings than in the business itself.

[cocker] 17/1/2017 08:38

Its not about second guessing, more about having the truth placed in front of you. Last years TU was out by now & this year it is not. They know the numbers so why keep them back. As I said earlier the share price has dropped almost 30% since the results, this after a decent 2mill contract. The market hates uncertainty & NOT giving a TU creates this. As I have said before, when there is good news from within, most companies like to shout it from the roof tops. Also totally agree with the above post on Integumen, not many second guessed that one

[yump] 17/1/2017 07:49

No point in trying to second-guess anything really is there ?

It doesn't take much to move the share price either way significantly, but some would be expecting more evidence of profitability by now, so perhaps its just those that have dropped the share price. If they'd been closer to profit it might have carried on up from the high twenties.

Plus the integumen decision was somewhat unexpected and that always creates worry.

Trying to positive spin it all though is just as pointless. Clearly if someone thought it was all great, they could pile in and shift the share price upwards.

[harry vederci] 16/1/2017 23:47

Looking at the recent share capital issues & bringing forward the reporting date by 5 months, both positives, seems to me Integumen is being rapidly positioned for IPO - hence expecting a 'consolidated' trading statement



interesting times ahead!

[cocker] 16/1/2017 16:07

Since the end of Sept & having secured a 2.5mill contract the share price has lost almost 30% of its value. Well obviously some of you are happy with that, I guess I am not & having witnessed over many years the way in which many directors on AIM behave I am some what concerned. Innovenn isn't being played out how many of us thought it was going to be either. Like I said in an earlier post, I hope I am wrong but we will see.

[rivaldo] 16/1/2017 14:57

Cheers harry. Good to hear no red flags apparent.

They're probably going to combine the trading statement with concrete progress on the Integumen IPO, which is perfectly understandable - there's little point in issuing a trading update which is lacking detail on the major item on the agenda at present.

[harry vederci] 16/1/2017 14:00

spoke to co. last week. No red flags apparant, but they play it by the book & no sensitive info. given out, expect a trading statement later this month

[rivaldo] 16/1/2017 13:34

A bit of movement today, on very small volumes. Anyone got news on how the Integumen IPO is progressing?

[investordave] 12/1/2017 10:42

Let's hope so.

[cocker] 12/1/2017 07:13

Only Friday the 13th left this week to give a TU which does not bode well. Last year TU was on the 8th & in my experience these little aim listed companies like very much to get good news out in the public domain, where as bad or not so good always seems to be held back. For all our sakes lets hope I am well wide of the mark.

[cocker] 06/1/2017 18:48

Quite possible that a TU will come next week. However, if it comes with a fund raising, I am off.

[shanklin] 06/1/2017 17:12

There was an EOY TS on 08-Jan-16, so presumably there will be a trading statement issued some time next week.